Insiders Twist Bioscience Corporation

Equities

Market Closed - Nasdaq Other stock markets 03:59:47 2024-06-04 pm EDT			5-day change	1st Jan Change
46.98 ^USD	+6.75%		+10.70%	+27.46%

Jun. 04	Guggenheim Initiates Twist Bioscience With Buy Rating, $53 Price Target	MT
May. 22	Oxford Nanopore Technologies Collaborates with Twist Bioscience to Launch Pharmacogenomics Beta Programme and Advance Personalised Medicine	CI

Twist Bioscience Names Adam Laponis Chief Financial Officer	Jan. 05	MT
Twist Bioscience Corporation Appoints Adam Laponis as Principal Financial Officer, Effective January 8, 2024	Jan. 05	CI
Twist Bioscience Appoints Adam Laponis as Chief Financial Officer	Jan. 05	CI
Twist Bioscience Corporation Appoints Mark Buck as Senior Vice President, Operations	23-10-03	CI
Twist Bioscience Appoints Chet Gandhi as Chief Information Officer	23-06-20	CI
Twist Bioscience Corporation Announces the Appointment of Robert Werner as Chief Accounting Officer	23-05-23	CI
Twist Bioscience Chief Accounting Officer Kevin Yankton to Step Down	23-03-28	MT
Twist Bioscience Corporation Announces Chief Accounting Officer Changes, Effective May 19, 2023	23-03-28	CI
Twist Bioscience Appoints Patrick Finn Chief Operating Officer	22-10-26	MT
Twist Bioscience Promotes Patrick Finn, Ph.D., to President and Chief Operating Officer	22-10-26	CI
Insider Sell: Twist Bioscience	22-08-18	MT
Insider Sell: Twist Bioscience	22-05-24	MT
Twist Bioscience Corporation Announces Management Changes	22-04-22	CI
Insider Sell: Twist Bioscience	22-04-18	MT
Abveris Named as One of the Best Places to Work	22-03-10	BU
Insider Sell: Twist Bioscience	21-12-30	MT
Insider Sell: Twist Bioscience	21-12-23	MT
Insider Sell: Twist Bioscience	21-12-06	MT
Insider Sell: Twist Bioscience	21-11-23	MT
Twist Bioscience Corporation Announces Executive Changes	21-11-23	CI

No results for this search